Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07466290

L-serine and Strength Training in the Elderly

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
University of Vienna · Academic / Other
Sex
All
Age
65 Years – 85 Years
Healthy volunteers
Accepted

Summary

This study investigates whether taking the amino acid L-serine, either alone or in combination with targeted strength training, can have a positive effect on mental performance, brain function, and physical fitness in older people. Healthy, independent women and men aged 65 to 85 are eligible to participate. Participants will be randomly assigned to one of three groups: placebo, L-serine, or L-serine combined with strength training. Cognitive tests, physical performance tests, and blood and brain tests will be conducted over a period of 48 weeks. The aim is to gain a better understanding of how nutrition and exercise can contribute to healthy aging.

Detailed description

The study is a randomized, controlled, double-blind intervention study with three parallel groups of healthy older adults (aged 65-85). It investigates the effects of L-serine supplementation with and without accompanying strength training on cognitive, neural, molecular, and functional parameters over 48 weeks. The primary endpoint is the change in cognitive performance, measured using the composite RBANS score. Secondary endpoints include structural and functional brain parameters (MRI, EEG), psychosocial parameters, markers of oxidative stress and immune function, as well as physical performance and muscle mass.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStrength trainingStructured strength training 2x/week
DIETARY_SUPPLEMENTL-serine supplementationL-serine supplementation 6g/day
DIETARY_SUPPLEMENTControl (cornstarch)Placebo 6g cornstarch/day, No strength training

Timeline

Start date
2026-03-01
Primary completion
2027-12-01
Completion
2028-12-01
First posted
2026-03-12
Last updated
2026-03-12

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT07466290. Inclusion in this directory is not an endorsement.